FEATURED4 years ago
Hetero, Cipla gets the DCGI node to develop remdesivir for COVID-19 patients in India
A day after the DCGI gave nodes to Glenmark for the manufacture and commercialization of favipiravir for treating COVID-19 patients, Hetero and Cipla were also able...